Custom-designed CRISPR gene editors delivered in mRNA format for clinical and research applications. Provides scalable solutions for therapeutic genome editing workflows.
Manufactured by
Synthego
United States
Synthego develops scalable solutions for CRISPR research, molecular biology, and diagnostic workflows, serving the cell and gene therapy sector. The company specializes in custom CRISPR gene editors available in mRNA and protein formats designed for clinical applications, along with engineered cytosine base editors that eliminate double-strand breaks to enhance safety in therapeutic development. Synthego offers rapid, high-yield protein production capabilities using controlled, scalable systems independent of live cell culture. These solutions enable researchers and manufacturers to accelerate development of advanced therapeutics with improved fidelity and manufacturing flexibility.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Helio Diagnostics
France · 2 relevant products
GeneCker Co., Ltd.
South Korea · 1 relevant product
PAN-Biotech GmbH
Germany · 2 relevant products
26 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 36 closest product alternatives
Helio Diagnostics · France
Custom plasmid design and manufacturing for diagnostic and research applications. Supports product development and assay validation with GMP-compliant production available.
GeneCker Co., Ltd. · South Korea
Ultra-precision CRISPR/Cas9 technology platform for selective cleavage of wild-type DNA sequences. Enables targeted amplification of mutant DNA for diagnostic applications. Supports standardized liquid biopsy analysis.
PAN-Biotech GmbH · Germany
Specialized cell culture media and serum-free solutions designed for cell and gene therapy, mRNA technology, vaccine, and antibody production. Formulated to support biopharmaceutical manufacturing processes across research and clinical applications.
33 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products